Literature DB >> 24090729

Evidence and recommendations for imaging liver fat in children, based on systematic review.

Hannah I Awai1, Kimberly P Newton2, Claude B Sirlin3, Cynthia Behling4, Jeffrey B Schwimmer5.   

Abstract

BACKGROUND & AIMS: Fatty liver is a common problem in children and increases their risk for cirrhosis, diabetes, and cardiovascular disease. Liver biopsy is the clinical standard for diagnosing and grading fatty liver. However, noninvasive imaging modalities are needed to assess liver fat in children. We performed a systematic review of studies that evaluated imaging liver fat in children.
METHODS: We searched PubMed for original research articles in peer-reviewed journals from January 1, 1982, through December 31, 2012, using the key words "imaging liver fat." Studies included those in English, and those performed in children from birth to 18 years of age. To be eligible for inclusion, studies were required to measure hepatic steatosis via an imaging modality and a quantitative comparator as the reference standard.
RESULTS: We analyzed 9 studies comprising 610 children; 4 studies assessed ultrasonography and 5 studies assessed magnetic resonance imaging (MRI). Ultrasonography was used in the diagnosis of fatty liver with positive predictive values of 47% to 62%. There was not a consistent relationship between ultrasound steatosis score and the reference measurement of hepatic steatosis. Liver fat as measurements by MRI or by spectroscopy varied with the methodologies used. Liver fat measurements by MRI correlated with results from histologic analyses, but sample size did not allow for an assessment of diagnostic accuracy.
CONCLUSIONS: Available evidence does not support the use of ultrasonography for the diagnosis or grading of fatty liver in children. Although MRI is a promising approach, the data are insufficient to make evidence-based recommendations regarding its use in children for the assessment of hepatic steatosis.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Evidence-Based Medicine; Liver Imaging; NAFLD

Mesh:

Year:  2013        PMID: 24090729      PMCID: PMC3969892          DOI: 10.1016/j.cgh.2013.09.050

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  38 in total

1.  Relaxation effects in the quantification of fat using gradient echo imaging.

Authors:  Mark Bydder; Takeshi Yokoo; Gavin Hamilton; Michael S Middleton; Alyssa D Chavez; Jeffrey B Schwimmer; Joel E Lavine; Claude B Sirlin
Journal:  Magn Reson Imaging       Date:  2008-02-21       Impact factor: 2.546

2.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

3.  Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling.

Authors:  Huanzhou Yu; Ann Shimakawa; Charles A McKenzie; Ethan Brodsky; Jean H Brittain; Scott B Reeder
Journal:  Magn Reson Med       Date:  2008-11       Impact factor: 4.668

4.  Non-invasive means of measuring hepatic fat content.

Authors:  Sanjeev-R Mehta; E-Louise Thomas; Jimmy-D Bell; Desmond-G Johnston; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

5.  MRI in identifying hepatic steatosis in obese children and relation to ultrasonography and metabolic findings.

Authors:  Carlo Pozzato; Giovanni Radaelli; Chiara Dall'Asta; Elvira Verduci; Anna Villa; Chiara Villa; Silvia Scaglioni; Enrica Riva; Antonio E Pontiroli; Gianpaolo Cornalba; Marcello Giovannini
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-10       Impact factor: 2.839

6.  Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.

Authors:  Takeshi Yokoo; Mark Bydder; Gavin Hamilton; Michael S Middleton; Anthony C Gamst; Tanya Wolfson; Tarek Hassanein; Heather M Patton; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2009-02-12       Impact factor: 11.105

7.  Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.

Authors:  Nicolas Mennesson; Jérôme Dumortier; Valérie Hervieu; Laurent Milot; Olivier Guillaud; Jean-Yves Scoazec; Frank Pilleul
Journal:  J Comput Assist Tomogr       Date:  2009 Sep-Oct       Impact factor: 1.826

Review 8.  Noninvasive assessment of hepatic steatosis.

Authors:  Sameer M Mazhar; Masoud Shiehmorteza; Claude B Sirlin
Journal:  Clin Gastroenterol Hepatol       Date:  2008-12-06       Impact factor: 11.382

9.  Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD).

Authors:  Poonam Mishra; Zobair M Younossi
Journal:  Am J Gastroenterol       Date:  2007-12       Impact factor: 10.864

10.  Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis.

Authors:  Fiona Hughes Cassidy; Takeshi Yokoo; Lejla Aganovic; Robert F Hanna; Mark Bydder; Michael S Middleton; Gavin Hamilton; Alyssa D Chavez; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiographics       Date:  2009 Jan-Feb       Impact factor: 5.333

View more
  39 in total

1.  Hepatic fat quantification magnetic resonance for monitoring treatment response in pediatric nonalcoholic steatohepatitis.

Authors:  Hong Koh; Seung Kim; Myung-Joon Kim; Hyun Gi Kim; Hyun Joo Shin; Mi-Jung Lee
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

Review 2.  Clinical advances in pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer
Journal:  Hepatology       Date:  2016-03-04       Impact factor: 17.425

3.  Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children.

Authors:  Kevin A Zand; Amol Shah; Elhamy Heba; Tanya Wolfson; Gavin Hamilton; Jessica Lam; Joshua Chen; Jonathan C Hooker; Anthony C Gamst; Michael S Middleton; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2015-04-03       Impact factor: 4.813

4.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

Review 5.  Epidemiology of fatty liver: an update.

Authors:  Giorgio Bedogni; Valerio Nobili; Claudio Tiribelli
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

6.  An update on the role of the microbiome in non-alcoholic fatty liver disease pathogenesis, diagnosis, and treatment.

Authors:  Marialena Mouzaki; Rohit Loomba
Journal:  Curr Treat Options Gastroenterol       Date:  2020-05-02

Review 7.  The Genetics of Pediatric Nonalcoholic Fatty Liver Disease.

Authors:  Nidhi P Goyal; Jeffrey B Schwimmer
Journal:  Clin Liver Dis       Date:  2017-10-05       Impact factor: 6.126

8.  High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance.

Authors:  J Cai; C H Wu; Y Zhang; Y Y Wang; W D Xu; T C Lin; S X Li; L H Wang; J Zheng; Y Sun; W Liu; T Tao
Journal:  Int J Obes (Lond)       Date:  2017-05-10       Impact factor: 5.095

9.  Incidence of Nonalcoholic Fatty Liver Disease in Children: 2009-2018.

Authors:  Amandeep K Sahota; Warren L Shapiro; Kimberly P Newton; Steven T Kim; Joanie Chung; Jeffrey B Schwimmer
Journal:  Pediatrics       Date:  2020-12       Impact factor: 7.124

10.  Pediatric Nonalcoholic Fatty Liver Disease: A Report from the Expert Committee on Nonalcoholic Fatty Liver Disease (ECON).

Authors:  Rohit Kohli; Shikha Sunduram; Marialena Mouzaki; Sabina Ali; Pushpa Sathya; Stephanie Abrams; Stavra A Xanthakos; Miriam Vos; Jeffrey B Schwimmer
Journal:  J Pediatr       Date:  2016-01-01       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.